TR200300575T3 - Miyopati ile bağlantılı dikkat bozukluklarını düzeltme amaçlı bir ilacın imalatı için modafinilin kullanılması - Google Patents

Miyopati ile bağlantılı dikkat bozukluklarını düzeltme amaçlı bir ilacın imalatı için modafinilin kullanılması

Info

Publication number
TR200300575T3
TR200300575T3 TR2003/00575T TR200300575T TR200300575T3 TR 200300575 T3 TR200300575 T3 TR 200300575T3 TR 2003/00575 T TR2003/00575 T TR 2003/00575T TR 200300575 T TR200300575 T TR 200300575T TR 200300575 T3 TR200300575 T3 TR 200300575T3
Authority
TR
Turkey
Prior art keywords
modafinilin
myopathy
drug
correction
manufacture
Prior art date
Application number
TR2003/00575T
Other languages
English (en)
Inventor
Fabrice@Battaglia
Jean@Krieger
Christophe@Petiau
Christophe@@Vial
Helene@Bastuji
Serge@Lubin
Original Assignee
Cephalon@France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon@France filed Critical Cephalon@France
Publication of TR200300575T3 publication Critical patent/TR200300575T3/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Abstract

Bulus, miyopati gelisimi esnasinda gözlemlenen dikkat bozukluklarini düzeltme amaçli bir ilacin imalati için modafinil ve izomerlerinin kullanimi ile ilgilidir.
TR2003/00575T 2000-01-31 2001-01-29 Miyopati ile bağlantılı dikkat bozukluklarını düzeltme amaçlı bir ilacın imalatı için modafinilin kullanılması TR200300575T3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0001211A FR2804322B1 (fr) 2000-01-31 2000-01-31 Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies

Publications (1)

Publication Number Publication Date
TR200300575T3 true TR200300575T3 (tr) 2003-06-23

Family

ID=8846505

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/00575T TR200300575T3 (tr) 2000-01-31 2001-01-29 Miyopati ile bağlantılı dikkat bozukluklarını düzeltme amaçlı bir ilacın imalatı için modafinilin kullanılması

Country Status (13)

Country Link
US (1) US6462089B1 (tr)
EP (1) EP1251842B1 (tr)
JP (2) JP2003521487A (tr)
AT (1) ATE247956T1 (tr)
AU (1) AU2001231931A1 (tr)
DE (1) DE60100660T2 (tr)
DK (1) DK1251842T3 (tr)
ES (1) ES2206400T3 (tr)
FR (1) FR2804322B1 (tr)
MX (1) MXPA02007236A (tr)
PT (1) PT1251842E (tr)
TR (1) TR200300575T3 (tr)
WO (1) WO2001054648A2 (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001283008A1 (en) * 2000-07-27 2002-02-13 Teva Pharmaceutical Industries Ltd. Crystalline and pure modafinil, and process of preparing the same
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
CA2556106A1 (en) * 2004-02-06 2005-08-25 Cephalon, Inc. Modafinil compositions
CN100343228C (zh) * 2006-02-17 2007-10-17 中国科学院上海有机化学研究所 高对映体选择性制备 2－二苯甲基亚磺酰基－乙酰胺单一对映体的方法
WO2008003093A2 (en) * 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue

Also Published As

Publication number Publication date
MXPA02007236A (es) 2003-09-05
DE60100660D1 (de) 2003-10-02
DE60100660T2 (de) 2004-02-26
WO2001054648A2 (fr) 2001-08-02
ATE247956T1 (de) 2003-09-15
US6462089B1 (en) 2002-10-08
AU2001231931A1 (en) 2001-08-07
DK1251842T3 (da) 2003-12-22
ES2206400T3 (es) 2004-05-16
EP1251842A2 (fr) 2002-10-30
EP1251842B1 (fr) 2003-08-27
FR2804322A1 (fr) 2001-08-03
WO2001054648A3 (fr) 2002-06-06
PT1251842E (pt) 2004-01-30
FR2804322B1 (fr) 2002-04-19
JP2012197304A (ja) 2012-10-18
JP2003521487A (ja) 2003-07-15

Similar Documents

Publication Publication Date Title
TR200300575T3 (tr) Miyopati ile bağlantılı dikkat bozukluklarını düzeltme amaçlı bir ilacın imalatı için modafinilin kullanılması
CY1105729T1 (el) Παραγοντες με σχετιζομενη με σεροτονινη δραση για την αντιμετωπιση για υπνικη απνοια
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
AP2002002481A0 (en) Biaryl ether derivatives useful as monoamine reuptake inhibitors.
CY1106375T1 (el) Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας
ATE479686T1 (de) Pyridopyrrolizin- und pyridoindolizinderivate
CY1109498T1 (el) 18-μεθυλο-19-νορ-17-πρεγν-4-ενο-21,17-καρβολακτονες καθως και φαρμακευτικα σκευασματα που τις περιεχουν
ECSP055704A (es) 4-(indazol-3-il) fenoles sustituidos como ligandos del receptor de estrógeno (re) y su uso en el tratamiento de enfermedades inflamatorias
MY147181A (en) Prostaglandin derivatives.
ECSP055533A (es) Compuestos de fenilsulfonamida sustituida inhibidores de la producción de beta-amiloide
AR028258A1 (es) Compuestos con actividad agonista de 5-ht2 y 5-ht1a para el tratamiento de trastornos de la retina externa
DK1735296T3 (da) Materialer og fremgangsmåder til behandling af koagulationslidelser
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
CY1105526T1 (el) Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης
MXPA05009282A (es) Derivados de anilina sustituidos.
CY1105403T1 (el) Χρηση της ακετυλο-l-καρνιτινης σε συνδυασμο με τη βιοτινη για τη θepαπεια ασθενων με ινσουλινο-ανθεκτικο σακχαρωδη διαβητη τυπου 2
DE60335563D1 (de) Verwendung von 3-positions-cyclosporin-derivaten für haarwachstum
TR200201249T2 (tr) 15-hidroksieikosatetraenoik asitin heteroatomun araya girdiği analogları ve bunların kullanım yöntemleri.
SG171472A1 (en) Substituted aniline derivatives
DE60009315D1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
EA200501499A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ п-ДИАМИНОБЕНЗОЛА
DE60009032T2 (de) Benzolsulfonamid-derivate und ihre verwendung
DE602005010694D1 (de) Piperazinderivate von alkyloxindolen
EA200501053A1 (ru) Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы